When tested in a co-culture system of T47D breast cancer cells with human breast adipose fibroblasts (BAFs), resveratrol (20 μM) promoted an aromatase inhibitory effect as potent as 20 nM of letrozole, which is a clinically used anti-aromatase drug in breast cancer treatment [176]. The gene discussed is CYP19A1; the disease is breast cancer.